期刊文献+

中空介孔硅球对血管内皮细胞的细胞毒性

Cytotoxicity of hollow mesoporous silica nanoparticles on human umbilical vein endothelial cells
下载PDF
导出
摘要 通过细胞增殖实验和乳酸脱氢酶释放实验,流式细胞术,透射电镜及电感耦合等离子体发射光谱仪检测等方法,证实HMSN在浓度超过62.5μg/mL时,会对人脐静脉血管内皮细胞产生毒性,半抑制浓度约为150μg/mL.高浓度下HMSN导致细胞增殖抑制和乳酸脱氢酶释放,使细胞周期阻滞在G1期,并最终诱导细胞坏死.同时发现HMSN粉体在细胞培养液中浸提后,其浸提液在稀释比例小于1/64时仍有毒性,同样会抑制内皮细胞的增殖,并诱导细胞坏死.HMSN的毒性可能来源于HMSN颗粒本身对细胞和亚细胞结构的物理损伤作用,以及在细胞内降解产物的化学损伤作用.因此,使用HMSN递送抗癌药物应注意控制载体单次用量,避免对正常组织血管的毒性,促进对肿瘤组织血管的破坏. In this study the cytotoxicity caused by HMSN to human umbilical vessel endothelial cells(HUVECs) was examined by inhibition of cell proliferation,lactate dehydrogenase(LDH) release assay,flow cytometer analysis,transmission electron microscopy(TEM) and indictive coupled plasma-atomic emission spectroscopy(ICP-AES).The results showed that HMSN at the concentration more than 62.5μg/mL will exert cytotoxicity on HUVECs and the IC50 is 150μg/mL.At high concentration HMSN significantly inhibited the proliferation of HUVECs, causing LDH release,arrest cell cycle at G1 period and eventually induced necrosis.The extracts of HMSN also had the same effect on HUVECs at different dilution ratios less than 1:64,indicating the degradation product of HMSN had cytotoxicity.The cytotoicity may come from the physical damage on cell structure by HMSN,and chemical disturbance on metabolism caused by product of HMSN degradation.Therefore,attentions should be paid on the single dosage,avoiding cytotoxicity to normal tissue vessels;stimulating cytotoxicity to tumor vessel.
出处 《华东师范大学学报(自然科学版)》 CAS CSCD 北大核心 2011年第2期142-151,共10页 Journal of East China Normal University(Natural Science)
基金 国家高技术发展计划(863)(2007AA03Z317)
关键词 中空介孔硅球 粉体浸提液 血管内皮细胞 细胞毒性 hollow mesoporous silica nanoparticles extracts of HMSN human umbilical vein endothelial cells cytotoxicity
  • 相关文献

参考文献25

  • 1SLOWING I I, VIVERO-ESCOTO J L, WU C W, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers[J]. Adv Drug Deliv Rev, 2008, 60: 1278-88.
  • 2VALLET-REGi M, BALAS F, ARCOS D. Mesoporous materials for drug delivery[J]. Angew Chem Int Ed, 2007, 46 : 7548-7558.
  • 3VALLET-REGI M, RAMILA A, REAL RPL, et al. A new property of MCM-41: drug delivery system[J]. Chem Mater, 2001, 13: 308-311.
  • 4ZHU Y, SHI J, SHEN W, et al. Stimuli-responsive controlled drug release from a hollow mesoporous silica sphere/polyelectrolyte multilayer core-shell structure[J]. Angew Chem Int Ed, 2005, 44: 5083-5087.
  • 5ZHU Y, SHI J, CHEN H, et al. A facile method to synthesize novel hollow mesoporous silica spheres and ad- vanced storage property[J]. Micropor Mesopor Mater, 2005, 84: 218-222.
  • 6SONG S W, HIDAJAT K, KAWI S. Funetionalized SBA-15 materials as carriers for controlled drug delivery; influence of surface properties on matrix? drug interactions[J]. Langmuir, 2005, 21: 9568-9575.
  • 7QU F, ZHU G, LIN H, et al. A controlled release of ibuprofen by systematically tailoring the morphology of me- soporous silica materials[J]. J Solid State Ch, 2006, 179:2027-2035.
  • 8ZHU Y, SHI J A mesoporous core-shell structure for pH-controlled storage and release of water-soluble drug[J]. Micropor Mesopor Mater, 2007, 103 : 243-249.
  • 9QU F, ZHU G, HUANG S, et al. Controlled release of Captopril by regulating the pore size and morphology of ordered mesoporous silica[J]. Mieropor Mesopor Mater, 2006, 92: 1-9.
  • 10LU J, LIONG M, ZINK J I, et al. Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs[J]. Small, 2007 (3): 1341-1346.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部